Patent classifications
A
HUMAN NECESSITIES
Load children
A61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
Load children
A61B
DIAGNOSIS; SURGERY; IDENTIFICATION
Load children
5/00
Measuring for diagnostic purposes; Identification of persons Display name: Medical measurements for diagnostic or identification purposes
Load children Filter patents View analytics View as hierarchy Open in page
A61B5/42
Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
Load children Filter patents View analytics View as hierarchy Open in page
A61B5/4222
Evaluating particular parts, e.g. particular organs
Load children Filter patents View analytics View as hierarchy Open in page

A61B5/4222

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028027 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028027 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028028 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028028 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028029 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028029 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028030 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
20170028030 · 2017-02-02 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Treatment of short bowel syndrome patients with colon-in-continuity
09555079 · 2017-01-31 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Treatment of short bowel syndrome patients with colon-in-continuity
09555079 · 2017-01-31 · ·

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.